SCHEMBL29569518

SCHEMBL29569518

O=c1ccc(-c2cnc(OCC(F)(F)F)nc2)nn1Cc1ccc(OC(F)F)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.40
▸ GRIN1 Q05586 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ DAO P14920 1/20 0.36
▸ HCRTR1 O43613 2/20 0.35
▸ HCRTR2 O43614 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ PTGES O14684 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MET P08581 4/20 0.34
▸ PDE4A P27815 1/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ PDE4C Q08493 1/20 0.34
▸ PDE4D Q08499 1/20 0.34
▸ TRPV3 Q8NET8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23558984 1.00 CYP1A2 (0.40) CYP1A2GRIN1GRIN2BDAOHCRTR1
SCHEMBL26998998 0.92 CYP1A2 (0.39) CYP1A2GRIN1GRIN2BPOLBMEN1
SCHEMBL29569470 0.88 CYP11B1 (0.43) CYP1A2GRIN1GRIN2BPOLBMEN1
SCHEMBL23528550 0.88 CYP11B1 (0.43) CYP1A2GRIN1GRIN2BPOLBMEN1
SCHEMBL26234992 0.85 MEN1 (0.37) GRIN1GRIN2BPOLBMEN1KMT2A
SCHEMBL23528790 0.85 MAPT (0.39) CYP1A2GRIN1GRIN2BPOLBMEN1
SCHEMBL23559024 0.84 POLB (0.40) POLBMEN1KMT2AHDAC1MAPT
SCHEMBL29569742 0.84 MEN1 (0.41) GRIN1GRIN2BPOLBMEN1KMT2A
SCHEMBL29569959 0.84 POLB (0.40) POLBMEN1KMT2AHDAC1MAPT
SCHEMBL23558978 0.84 MEN1 (0.41) GRIN1GRIN2BPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250223278-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. 2025-07-10 — — US disclosed
US-12240831-B2 Pyridazinone compounds and uses thereof EDGEWISE THERAPEUTICS, INC. (US) 2025-03-04 — — US disclosed
US-12012395-B2 Pyridazinone compounds and uses thereof EDGEWISE THERAPEUTICS, INC. (US) 2024-06-18 — — US disclosed
US-20240025879-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. 2024-01-25 — — US disclosed
US-20220106291-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. 2022-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12012395-B2 Pyridazinone compounds and uses thereof IL6, IL1B, IL1A CYP1A2 1767/4885GRIN1 894/4885GRIN2B 1997/4885
US-12240831-B2 Pyridazinone compounds and uses thereof IL6, IL1B, IL1A CYP1A2 1767/4885GRIN1 894/4885GRIN2B 1997/4885
US-20220106291-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF IL6, IL1B, IL1A CYP1A2 1767/4885GRIN1 894/4885GRIN2B 1997/4885
US-20250223278-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF IL6, IL1B, IL1A CYP1A2 1767/4885GRIN1 894/4885GRIN2B 1997/4885
US-20240025879-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF IL6, IL1B, IL1A CYP1A2 1767/4885GRIN1 894/4885GRIN2B 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback